Latest Exploration News

Constellation Resources has identified a significant gold-copper soil anomaly named Chatham at its Ularring Project in Western Australia, shifting exploration focus to this promising new target.

Far Northern Resources has reported impressive high-grade gold assay results from its Phase One drilling at the Bridge Creek mining lease, setting the stage for resource expansion along the Cosmo Howley anticline.

White Cliff Minerals appoints mining veteran John Hancock to its board and engages Astrotricha Capital as advisors, setting the stage for a major drilling campaign at the Rae Copper Project.

Many Peaks Minerals reports significant expansion of gold mineralisation at its Ferké Gold Project in Côte d’Ivoire, with diamond drilling revealing extensive high-grade zones. The company advances its exploration with multiple rigs and pending assay results.

Flagship Minerals has exited its lithium project in Chile amid market oversupply, redirecting resources to its Pantanillo Gold Project with a significant 1.05 million ounce gold resource estimate.

DeSoto Resources has reported promising high-grade gold assay results from a recent shallow power auger drilling program at its Dadjan Gold Project in Guinea’s prolific Siguiri Basin. The findings confirm extensive gold anomalism along key structural trends, reinforcing the project’s exploration potential.

Sierra Nevada Gold’s recent auger sampling at New Pass reveals promising gold grades in historic tailings, bolstering plans for mine reactivation and processing trials.

Legacy Iron Ore Limited announces a significant leadership reshuffle with CEO Rakesh Gupta stepping down immediately and Dr Ranajit Das appointed to lead the company from July 2025. Ben Donovan also joins the board as a Non-Executive Director.

Revolver Resources has completed the final milestone of a Queensland government grant, unlocking full funding to fast-track its Dianne Copper Mine Project towards production in 2026.

Duketon Mining has identified a significant new gold anomaly at its Killarney Project and is set to commence its first reverse circulation drilling campaign targeting high-grade extensions.

Amplia Therapeutics has secured US ethics approval to launch a Phase 2 trial combining its drug narmafotinib with FOLFIRINOX chemotherapy for advanced pancreatic cancer, marking a key step in its clinical development.

Lefroy Exploration has reported strong, consistent gold assay results from its Lucky Strike deposit, reinforcing confidence in its resource model as it advances towards mining operations targeted for early 2026.